Treatment of graft versus host disease with photopheresis interferes in voriconazole therapeutic drug monitoring: A case study
Extracorporeal photopheresis is an established procedure for refractory graft-versus-host disease, a major complication associated with notable morbidity and mortality in patients with allogeneic hematopoietic stem cell transplant. Despite being implemented over a decade ago, there is scant informat...
Main Authors: | Adriana Sassone, Juliana Testard, Andrea Saulo, Analia Julia, Paula Schaiquevich |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-11-01
|
Series: | Practical Laboratory Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352551723000343 |
Similar Items
-
Safety and Efficacy of Extracorporeal Photopheresis for Acute and Chronic Graft-versus-Host Disease
by: Eleni Gavriilaki, et al.
Published: (2024-09-01) -
Extracorporeal photopheresis in the treatment of graft-versus-host disease
by: I. V. Guz, et al.
Published: (2016-03-01) -
Extracorporeal Photopheresis in Children with Chronic Graft-Versus-Host Disease
by: Andrey Kozlov, et al.
Published: (2021-08-01) -
Extracorporeal photopheresis for the treatment of chronic graft versus host disease
by: Emin Kansu, et al.
Published: (2022-12-01) -
Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresis
by: Mauricio Sarmiento Maldonado, et al.
Published: (2017-12-01)